[
  {
    "ts": null,
    "headline": "What $6,500 a Month Really Looks Like in Retirement at 67",
    "summary": "Retiring at 67 with $6,500 in monthly income places you solidly in middle-class territory, but the financial reality behind that figure is more nuanced than it appears. With average Social Security benefits at $2,017 per month in 2026, a retiree targeting $6,500 needs to generate roughly $4,483 monthly—or $53,796 annually—from personal savings and investments. The ... What $6,500 a Month Really Looks Like in Retirement at 67",
    "url": "https://finnhub.io/api/news?id=6893e956b6faae41cdb1adaa3ed4f00fff9f2f71cae9fb0f95d173a221eb60ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768240904,
      "headline": "What $6,500 a Month Really Looks Like in Retirement at 67",
      "id": 138078048,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Retiring at 67 with $6,500 in monthly income places you solidly in middle-class territory, but the financial reality behind that figure is more nuanced than it appears. With average Social Security benefits at $2,017 per month in 2026, a retiree targeting $6,500 needs to generate roughly $4,483 monthly—or $53,796 annually—from personal savings and investments. The ... What $6,500 a Month Really Looks Like in Retirement at 67",
      "url": "https://finnhub.io/api/news?id=6893e956b6faae41cdb1adaa3ed4f00fff9f2f71cae9fb0f95d173a221eb60ef"
    }
  },
  {
    "ts": null,
    "headline": "How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?",
    "summary": "At 60 years old with $2 million saved, you can safely say that you are in a good position that most people will never reach. At this point, the question in your mind should shift from whether you have enough to retire to how much income you can generate from a $2 million portfolio to ... How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?",
    "url": "https://finnhub.io/api/news?id=fedc778d52b52655d54a7391294fa295505d3844360c695d47304ffb582809d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768240167,
      "headline": "How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?",
      "id": 138078053,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "At 60 years old with $2 million saved, you can safely say that you are in a good position that most people will never reach. At this point, the question in your mind should shift from whether you have enough to retire to how much income you can generate from a $2 million portfolio to ... How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?",
      "url": "https://finnhub.io/api/news?id=fedc778d52b52655d54a7391294fa295505d3844360c695d47304ffb582809d7"
    }
  },
  {
    "ts": null,
    "headline": "‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.",
    "summary": "Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",
    "url": "https://finnhub.io/api/news?id=a8e42fa0176125b6d61a239d1fc7e9d3ac654534ef8fe6ce6ee1a22fdfcc0ed8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768235880,
      "headline": "‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.",
      "id": 138076408,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",
      "url": "https://finnhub.io/api/news?id=a8e42fa0176125b6d61a239d1fc7e9d3ac654534ef8fe6ce6ee1a22fdfcc0ed8"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript",
    "summary": "Johnson & Johnson (JNJ) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 11:15 AM ESTCompany ParticipantsJoaquin Duato - CEO &...",
    "url": "https://finnhub.io/api/news?id=0f19fc8c16752d237337938a2991dbf249d63a5cb0b76f3db3f1a91e25b6a07e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768226762,
      "headline": "Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript",
      "id": 138077188,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson (JNJ) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 11:15 AM ESTCompany ParticipantsJoaquin Duato - CEO &...",
      "url": "https://finnhub.io/api/news?id=0f19fc8c16752d237337938a2991dbf249d63a5cb0b76f3db3f1a91e25b6a07e"
    }
  },
  {
    "ts": null,
    "headline": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System",
    "summary": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capit",
    "url": "https://finnhub.io/api/news?id=656167c7929d90e4f0f59c76b61821b15f0ec52dbf6f6db05ee116c4160a274d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768226400,
      "headline": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System",
      "id": 138072323,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capit",
      "url": "https://finnhub.io/api/news?id=656167c7929d90e4f0f59c76b61821b15f0ec52dbf6f6db05ee116c4160a274d"
    }
  }
]